1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan

• Samir Gupta,
• Michael B Atkins,
• Meredith Regan,
• Neil J Shah,
• Jacob Zaemes,
• Opeyemi A Jegede,
• Shaked Lev Ari,
• Lauren Pascual,
• Natali Arias-Orozco,
• Brittany Sinclaire,
• Alexandra DellaPia,
• Rachel A Zemel,
• Yili Zhang,
• Adil Alaoui,
• Andrew Ip

Affiliations

Samir Gupta

5 Medicine, St Michael`s Hospital, Toronto, Ontario, Canada

Michael B Atkins

1 Georgetown University, Washington, District of Columbia, USA

Meredith Regan

5Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA, USA

Neil J Shah

7Memorial Sloan Kettering Cancer Center, Washington, DC, USA

Jacob Zaemes

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA

Opeyemi A Jegede

Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Shaked Lev Ari

2Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Lauren Pascual

3John Theurer Cancer Center, Hackensack, NJ, USA

Natali Arias-Orozco

3John Theurer Cancer Center, Hackensack, NJ, USA

Brittany Sinclaire

3John Theurer Cancer Center, Hackensack, NJ, USA

Alexandra DellaPia

3John Theurer Cancer Center, Hackensack, NJ, USA

Rachel A Zemel

2Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Yili Zhang

5Georgetown University, Washington, DC, USA

Adil Alaoui

6Innovation Center for Biomedical Informatics at Georgetown University, Washington, DC, USA

Andrew Ip

3John Theurer Cancer Center, Hackensack, NJ, USA